Their report, «Commentary on key aspects of
fecal microbiota transplantation in small animal practice» (J. Chaitman, et al, Veterinary Medicine: Research and Reports, May 31, 2016), addressed FMT mechanisms, indications, donor selection, preparation, administration, safety, and regulation.
Going to the Bank:
Fecal Microbiota Transplantation in Pediatrics — Elaine Barfield — Clinical Pediatrics
Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and
Fecal Microbiota Transplantation in a Pediatric Hospital — Aileen Aldrich — The Pediatric Infectious Disease Journal
Fecal Microbiota Transplantation in Inflammatory Bowel Disease - a Primer for the Internists — Gaurav Syal — The American Journal of Medicine
Successful
Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation
Fecal microbiota transplantation in puppies with canine parvovirus infection — Giorgio Q. Pereira — Journal of Veterinary Internal Medicine
Fecal Microbiota Transplantation in Gestating Sows and Neonatal Offspring Alters Lifetime Intestinal Microbiota and Growth in Offspring — Ursula M McCormack — mSystems
Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and
Fecal Microbiota Transplantation in a Pediatric Hospital
Fecal microbiota transplantation in the management of hepatic encephalopathy.
Abstract: Sustained long - term improvement in clinical and cognitive outcomes after
fecal microbiota transplantation in cirrhosis (3161)
Not exact matches
Prof. Severine Vermeire (KU Leuven / UZ Leuven): «
In the future, gut bacteria may be used to help identify PSC patients with a more or less aggressive disease, or patients that may benefit from
microbiota - based therapies, such as
fecal microbiota transplantation or targeted pre - and probiotics.»
The procedure of transferring stool to a patient — technically called
fecal microbiota transplantation — was first performed
in the United States
in 1958 to treat an intractable case of C. difficile colitis, a gastrointestinal condition caused when the balance of microbes
in the gut — called the microbiome — is destabilized or destroyed.
In a retrospective, multicenter, longitudinal observational study, the response rates to
fecal microbiota transplantation as a treatment for recurrent C. difficile infection were determined a 30 and 90 days, and adverse events were registered.
«
Fecal microbiota transplantation produces sustained improvements
in cognitive and clinical outcomes.»
Fecal microbiota transplantation induces remission
in patients with active ulcerative colitis
in a randomized controlled trial.
Effect of Vegan
Fecal Microbiota Transplantation on Carnitine and Choline ‐ Derived Trimethylamine ‐ N ‐ Oxide Production and Vascular Inflammation
in Patients With Metabolic Syndrome — Loek P. Smits — Journal of the American Heart Association
Fecal microbiota transplantation and its potential therapeutic uses
in gastrointestinal disorders — Ryan D. Heath — Northern clinics of Istanbul
Finally, we will focus on the results of different therapeutic approaches
in this context: administration of pre - and probiotics, antibiotics,
fecal microbiota transplantation and special diets and dietary supplements.
Probiotics / prebiotics / antibiotics Tacrolimus concentration to dose ratio
in solid organ transplant patients treated with
fecal microbiota transplantation for recurrent Clostridium difficile infection.
Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial pro
Fecal microbiota transplantation inducing remission
in Crohn's colitis and the associated changes
in fecal microbial pro
fecal microbial profile.
Dr. Davis is one of a handful of physicians
in North America with clinical expertise
in fecal microbiota transplantation (FMT), which he offers via retention enema and capsule.